| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 30-Nov-08 | | Total Revenue | 3,037,000 | 7,306,000 | 6,689,000 | 6,593,000 | | Cost of Revenue | (1,536,000) | 821,000 | 715,000 | 389,000 | | | Gross Profit | 4,573,000 | 6,485,000 | 5,974,000 | 6,204,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,746,000 | 5,236,000 | 3,362,000 | 4,790,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | (1,387,000) | 115,000 | 1,272,000 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,786,000) | 1,134,000 | 1,340,000 | 1,414,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 1,263,000 | | Earnings Before Interest And Taxes | 2,873,000 | 1,134,000 | 1,340,000 | 2,677,000 | | Interest Expense | 1,658,000 | 1,776,000 | 2,225,000 | 5,998,000 | | Income Before Tax | 1,215,000 | (642,000) | (885,000) | (3,321,000) | | Income Tax Expense | 422,000 | (342,000) | (695,000) | (1,155,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 793,000 | (300,000) | (190,000) | (2,195,000) | | | Non-recurring Events | | Discontinued Operations |
-
| 333,000 |
-
| (100,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 886,000 | 33,000 | (190,000) | (2,295,000) | | Preferred Stock And Other Adjustments |
-
| 116,000 | 13,000 |
-
| | | Net Income Applicable To Common Shares | ($1,273,000) | $149,000 | ($177,000) | ($2,372,000) |
|
0.11% Nasdaq 
0.01%
Income Statement
